Article
In-vivo-targeted gene delivery using adenovirus-antibody site-specific covalent conjugates
26 May 2025
Abstract excerpt
performance is currently suboptimal and additional engineering is needed prior to further use, these studies form the basis of a novel method for targeting adenovirus that can be combined with additional well-characterized adenovirus modifications toward applications in cell engineering, gene therapy, vaccines, oncolytics, and others.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
